Breast Cancer

Study Sees Limited Need for Cancer Test

Published in Gene Therapy Weekly, April 6th, 1998

Screening women for a gene mutation linked to some breast cancers is not warranted except for those with a family history of breast or ovarian cancers, researchers reported.

The report from the University of North Carolina in Chapel Hill (UNC-CH) was based on a study of more than 600 black and white women, with and without breast cancer. The researchers said they found a low prevalence of the mutation - called BRCA1 - in women in general.

"Testing women from the general population for the entire (mutation) sequences is of questionable value, because a large number of women would be tested, expensively, to detect few mutations, and the negative...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1998-04-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry